FundedIQ
Biotechnology

Amplexd Therapeutics: Funding, Investors & Team (Oct 2026)

Amplexd Therapeutics is dedicated to creating non-invasive, topical treatments for HPV-induced cervical dysplasia, which can lead to cervical cancer. The company's goal is to offer accessible solutions to this public health problem and provide alternatives to conventional treatment methods for mild cases. With a passionate team, Amplexd Therapeutics is focused on advancing biotechnology with innovative treatments that improve patient outcomes in the battle against HPV-related conditions.

amplexd.com LinkedIn Gaithersburg, United States 1-10 employees
Total raised
$2.0M
Rounds
1
Latest
Seed
May 2024

Amplexd Therapeutics has raised $2.0M across 1 funding round on record, the most recent a Seed of $2.0M announced in May 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Amplexd Therapeutics Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$2.0M in May 2024
Employees
1-10
reported band
Headquarters
Gaithersburg, United States

Latest funding round on record: May 2024.

Amplexd Therapeutics Funding Rounds

Date
Round
Amount
Seed
$2.0M

Amplexd Therapeutics Founders and Leadership Team

Name
Role
Contact
Alia Rahman
Founder
Locked

Contact details for the Amplexd Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Amplexd Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Amplexd Therapeutics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Amplexd Therapeutics in Biotechnology and Gaithersburg

Companies Similar to Amplexd Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Amplexd Therapeutics Funding FAQs

What does Amplexd Therapeutics do?

Amplexd Therapeutics is dedicated to creating non-invasive, topical treatments for HPV-induced cervical dysplasia, which can lead to cervical cancer. The company's goal is to offer accessible solutions to this public health problem and provide alternatives to conventional treatment methods for mild cases. With a passionate team, Amplexd Therapeutics is focused on advancing biotechnology with innovative treatments that improve patient outcomes in the battle against HPV-related conditions.

How much funding has Amplexd Therapeutics raised?

Amplexd Therapeutics has raised $2.0M across 1 round on record. The most recent is a Seed of $2.0M announced in May 2024.

When did Amplexd Therapeutics last raise funding?

Amplexd Therapeutics' most recent funding round on record is a Seed of $2.0M, announced in May 2024.

Who founded Amplexd Therapeutics?

FundedIQ lists Alia Rahman (Founder) at Amplexd Therapeutics.

Where is Amplexd Therapeutics headquartered?

Amplexd Therapeutics is based in Gaithersburg, Maryland, United States.

How many employees does Amplexd Therapeutics have?

Amplexd Therapeutics is in the 1-10 employee band.

How does Amplexd Therapeutics' funding compare to other Biotechnology startups?

Amplexd Therapeutics' latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Amplexd Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Amplexd Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.